Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis
Endpoints for cancer clinical trials
Publication
, Chapter
George, ; Wang, ; Pang,
Duke Scholars
Start / End Page
3 / 36
Publisher
Chapman & Hall/CRC
Citation
APA
Chicago
ICMJE
MLA
NLM
George, ., Wang, ., & Pang, . (n.d.). Endpoints for cancer clinical trials. In . George (Ed.), Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis (pp. 3–36). Chapman & Hall/CRC.
George, J Todd, J Todd Wang, and J Todd Pang. “Endpoints for cancer clinical trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by J Todd George, 3–36. Chapman & Hall/CRC, n.d.
George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.
George, J. Todd, et al. “Endpoints for cancer clinical trials.” Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by J Todd George, Chapman & Hall/CRC, pp. 3–36.
George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.
Start / End Page
3 / 36
Publisher
Chapman & Hall/CRC